Alto Neuroscience (ANRO) Non Operating Income (2023 - 2026)
Alto Neuroscience (ANRO) reported Non Operating Income of $1.49 million for Q2 2026, up 52.8% from $976,000 a year earlier and up 65.5% from the prior quarter.
Powered by 
Analysis
Alto Neuroscience (ANRO) Non Operating Income (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Alto Neuroscience's Non Operating Income came in at $4.04 million, down 25.0% year-over-year; for FY2025, it was $3.13 million, down 56.5% from FY2024.
- By year, Non Operating Income came in at $7.18 million in FY2024 (+377.3%) and $1.5 million in FY2023.
- The Q2 2026 figure ranks as the highest quarterly Non Operating Income since Q4 2024.
- Year over year, Non Operating Income gained in four of the last eight quarters, with growth averaging 50.3%.
- The high point for year-over-year Non Operating Income in five years was Q2 2024 (growth of 400.2%); the low point was Q3 2025 (a decline of 63.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $901,000 (Q1 2026), $873,000 (Q4 2025) and $770,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Alto Neuroscience | 897.35 Mn | 897.35 Mn | - | 1.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.49 Mn |
| Mar 31, 2026 | 901,000.00 |
| Dec 31, 2025 | 873,000.00 |
| Sep 30, 2025 | 770,000.00 |
| Jun 30, 2025 | 976,000.00 |
| Mar 31, 2025 | 507,000.00 |
| Dec 31, 2024 | 1.80 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 969,000.00 |
| Dec 31, 2023 | 548,000.00 |
| Sep 30, 2023 | 577,000.00 |
| Jun 30, 2023 | 462,000.00 |
| Mar 31, 2023 | -83,000.00 |
API Access
Alto Neuroscience Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ANRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ANRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ANRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();